SCHEMBL3624030

SCHEMBL3624030

[CH2]Cc1ccccc1NC(C)N

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
TAAR1 Q96RJ0 2/20 0.32
MAOA P21397 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
CYP2A6 P11509 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
MDM4 O15151 1/20 0.31
TP53 P04637 1/20 0.31
BPTF Q12830 1/20 0.31
KAT2B Q92831 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10696771 0.73 LMNA (0.37) SLC6A2SLC6A4SLC6A3L3MBTL1TAAR1
SCHEMBL2536107 0.73 L3MBTL1 (0.43) L3MBTL1TAAR1SIGMAR1ALDH1A1MAPT
SCHEMBL18904614 0.71 MAPT (0.46) MAOASIGMAR1ALDH1A1GAAMAPT
SCHEMBL15430619 0.71 MAPT (0.45) SIGMAR1ALDH1A1GAAMAPTTP53
SCHEMBL10688898 0.69 CYP1A2 (0.45) SLC6A2SLC6A4SLC6A3ALDH1A1MAPT
SCHEMBL27984361 0.68 AOC1 (0.44) L3MBTL1TAAR1ALDH1A1GAAMAPT
SCHEMBL22133452 0.68 AOC1 (0.58) L3MBTL1TAAR1ALDH1A1GAABPTF
SCHEMBL3232676 0.67 CA12 (0.51) SIGMAR1ALDH1A1GAAMAPTTP53
SCHEMBL890885 0.67 CA12 (0.52) TAAR1ALDH1A1MAPTKAT2B
SCHEMBL3725975 0.67 CA12 (0.51) SIGMAR1ALDH1A1GAAMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081837-A1 PROCESS FOR PRODUCTION OF POWDER OF CAGE SILSESQUIOXANE COMPOUND ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-04-01 US disclosed
US-7122591-B2 Polyphenylene ether-based resin composition containing silicon compound ASAHI KASEI KABUSHIKI KAISHA (JP) 2006-10-17 US disclosed
US-20040138355-A1 Polyphentlene ether resin composition containing silicon compounds ASAHI KASEI CHEMICALS CORPORATION (JP) 2004-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081837-A1 PROCESS FOR PRODUCTION OF POWDER OF CAGE SILSESQUIOXANE COMPOUND DCPS, SFXN1, SMOX SLC6A2 4510/4885SLC6A4 3623/4885SLC6A3 4382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.